Related Experiment Video
Updated: Feb 20, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.6K
Decellularized Dermis ECM-Based Melanoma-on-a-Chip Model with Integrated Lymphatic and Vascular Networks for
Paula Vázquez-Aristizabal1,2,3, Inazio Arriola-Alvarez2, Malou Henriksen-Lacey1,3
1CIC biomaGUNE, Basque Research and Technology Alliance (BRTA), 20014 Donostia-San Sebastián, Spain.
ACS Applied Bio Materials
|February 18, 2026
Summary
This study developed a novel in vitro melanoma model using decellularized extracellular matrix and vascular structures for advanced drug screening. It effectively mimics the tumor microenvironment, aiding melanoma research and therapeutic development.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Drug Development
Background:
- Malignant melanoma treatment requires accurate models of the tumor microenvironment to study metastasis and drug response.
- Existing in vitro models often lack biomimetic extracellular matrices (ECM) and vascular components, limiting their complexity and applicability.
- Developing advanced in vitro systems is crucial for understanding melanoma progression and evaluating therapeutic strategies.
Purpose of the Study:
- To create a sophisticated in vitro melanoma model that incorporates both decellularized extracellular matrix (dECM) and functional blood and lymphatic vessels.
- To establish a high-throughput platform for studying melanoma metastasis, tumor-vascular interactions, and drug responses.
- To validate the model's efficacy for drug screening and therapeutic development in melanoma research.
Main Methods:
- Development of a triculture melanoma spheroid embedded within a dermal dECM hydrogel.
- Integration of blood and lymphatic vascular structures alongside the melanoma spheroid within a microfluidic platform.
- Utilizing immunostaining for canonical markers and morphological analysis to confirm microenvironment replication; performing cytotoxicity assays for drug testing.
Main Results:
- The developed in vitro model successfully recreated key aspects of the melanoma microenvironment, confirmed by immunostaining and morphology.
- Proof-of-concept drug testing demonstrated the model's suitability for high-throughput drug screening.
- The system effectively mimics tumor-vascular interactions, offering a biomimetic platform for research.
Conclusions:
- The novel in vitro melanoma model, featuring dECM and vascular components, provides a robust platform for studying melanoma.
- This model serves as a promising alternative for in vitro melanoma research, metastasis studies, and drug development.
- The high-throughput capabilities facilitate efficient screening of therapeutic responses and accelerate melanoma drug discovery.
